Neurocrine Biosciences, Inc. (BVMF:N1BI34)

Neurocrine Biosciences Revenue

Neurocrine Biosciences had revenue of $794.90M USD in the quarter ending September 30, 2025, with 27.78% growth. This brings the company's revenue in the last twelve months to $2.68B, up 19.61% year-over-year. In the year 2024, Neurocrine Biosciences had annual revenue of $2.36B with 24.81% growth.

• Revenue (ttm): $2.68B
• Revenue Growth: +19.61%
• P/S Ratio: 5.42
• Revenue / Employee: $1.49M
• Employees: 1,800
• Market Cap: 77.54B BRL

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.36B	468.20M	24.81%
Dec 31, 2023	1.89B	398.40M	26.76%
Dec 31, 2022	1.49B	355.20M	31.34%
Dec 31, 2021	1.13B	87.60M	8.38%
Dec 31, 2020	1.05B	257.80M	32.71%